Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Cancer Biology & Therapy|October 5, 2010
Cdc2/cyclin B1 regulates centrosomal Nlp proteolysis and subcellular localizationXuelian Zhao, Shunqian Jin, Yongmei Song, et al.
Rapid Communications in Mass Spectrometry : RCM|September 4, 2021
One-pot synthesis and multiple MS/MS fragmentation studies of phospholysine peptidesXuelian Zhao, Songsen Fu, Yufen Zhao, et al.
Nutrition Research (New York, N.Y.)|March 19, 2026
Higher dietary omega-3 polyunsaturated fatty acid intake is associated with reduced all-cause mortality in cancer survivors: A prospective cohort studyWentao Zang, Lanlan Li, Xuelian Zhao, et al.
Neurology India|September 9, 2022
Is there an Influence of Match and Mismatch of Venous Drainage Pattern on AVM Hemorrhagic Presentation?Xianli Lv, Jianjun Yu, Xuelian Zhao, et al.
Neural Regeneration Research|May 27, 2026
Glycation aging environment: Abnormal glycosylation and advanced glycation end products drive neural agingXuelian Zhao, Haoyuan Yin, Rui Du, et al.
The Neuroradiology Journal|March 4, 2020
Acute hemorrhagic cerebral artery dissection: Characteristics and endovascular treatmentXianli Lv, Jianjun Yu, Wei Zhang, et al.
Neurology India|November 10, 2022
Developmental Venous Anomalies and Arteriovenous Malformations Coordinately Drained by the Internal Cerebral Vein: Clues to PathogenesisMichael G Z Ghali, Jianjun Yu, Xuelian Zhao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2023
Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006-2030: A Bayesian Age-Period-Cohort Modeling StudyMeiwen Yuan, Xuelian Zhao, Honghao Wang, et al.
Neurology India|September 11, 2021
Endovascular Treatment of Small Wide-Neck Bifurcation Aneurysms with Single Solitaire AB Stent TechniqueXianli Lv, Wei Zhang, Xuelian Zhao, et al.
The Oncologist|November 10, 2025
An early relapse prediction model based on pathological features following neoadjuvant immunotherapy for hepatocellular carcinomaYanrui Pang, Xuelian Zhao, Xinxin Guo, et al.
Pageof 11